Literature DB >> 17288880

Contemporary management of tumors of the salivary glands.

Joseph M Scianna1, Guy J Petruzzelli.   

Abstract

Management of tumors of the salivary glands requires a detailed understanding of the anatomy and pathologic processes affecting these glands. Salivary glands give rise to benign and malignant neoplasms and are affected by a variety of systemic diseases. CT remains the most common primary imaging study; magnetic resonance imaging and ultrasound have also been explored. Fine-needle aspiration as part of the diagnostic evaluation remains controversial due to varying sensitivities and specificities. Surgical extirpation is the primary modality for management of tumors of the salivary glands. Parotid surgery carries a potentially high morbidity with possible unsightly scarring and facial nerve damage. Nontraditional surgical approaches and instrumentation, as well as facial nerve monitoring, can decrease the morbidity of a parotidectomy. In specific instances, malignant salivary gland tumors warrant cervical lymphadenectomy. Adjuvant therapy is primarily accomplished with radiation. Chemotherapy continues to play a palliative role in salivary gland malignancies; however, newer trials are investigating the therapeutic role of chemotherapy.

Entities:  

Mesh:

Year:  2007        PMID: 17288880     DOI: 10.1007/s11912-007-0011-6

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  42 in total

1.  Surface landmarks of the facial nerve trunk: a prospective measurement study.

Authors:  D S Wong
Journal:  ANZ J Surg       Date:  2001-12       Impact factor: 1.872

2.  Fine-needle aspiration cytology in parotid masses: our experience in Canterbury, New Zealand.

Authors:  Neil Riley; Robert Allison; Scott Stevenson
Journal:  ANZ J Surg       Date:  2005-03       Impact factor: 1.872

3.  Postparotidectomy facial nerve paralysis: possible etiologic factors and results with routine facial nerve monitoring.

Authors:  P Dulguerov; F Marchal; W Lehmann
Journal:  Laryngoscope       Date:  1999-05       Impact factor: 3.325

4.  Free vascularized nerve grafting for immediate facial nerve reconstruction.

Authors:  Yoshihiro Kimata; Minoru Sakuraba; Shigeyuki Hishinuma; Satoshi Ebihara; Ryuichi Hayashi; Takahiro Asakage
Journal:  Laryngoscope       Date:  2005-02       Impact factor: 3.325

5.  Acinic cell carcinoma of the parotid gland: a 15-year review limited to a single surgeon at a single institution.

Authors:  S Alex Kim; Robert H Mathog
Journal:  Ear Nose Throat J       Date:  2005-09       Impact factor: 1.697

6.  Treatment of salivary gland neoplasms with fast neutron radiotherapy.

Authors:  James G Douglas; Wui-jin Koh; Mary Austin-Seymour; George E Laramore
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-09

7.  The impact of malignant disease on facial nerve function after parotidectomy.

Authors:  Todd W Ellingson; James I Cohen; Peter Andersen
Journal:  Laryngoscope       Date:  2003-08       Impact factor: 3.325

8.  Primary parotid malignoma surgery in patients with normal preoperative facial nerve function: outcome and long-term postoperative facial nerve function.

Authors:  Orlando Guntinas-Lichius; Jens Peter Klussmann; Ulla Schroeder; Gero Quante; Markus Jungehuelsing; Eberhard Stennert
Journal:  Laryngoscope       Date:  2004-05       Impact factor: 3.325

9.  Metastatic cutaneous squamous cell carcinoma to the parotid: the role of surgery and adjuvant radiotherapy to achieve best outcome.

Authors:  Eddy Dona; Michael J Veness; Burcu Cakir; Gary J Morgan
Journal:  ANZ J Surg       Date:  2003-09       Impact factor: 1.872

10.  Concomitant chemoradiotherapy followed by adjuvant chemotherapy in parotid gland undifferentiated carcinoma.

Authors:  M Airoldi; A M Gabriele; P Gabriele; F Pedani; S Marchionatti; G Succo; F Beatrice; C Bumma
Journal:  Tumori       Date:  2001 Jan-Feb
View more
  7 in total

1.  The value of combining conventional, diffusion-weighted and dynamic contrast-enhanced MR imaging for the diagnosis of parotid gland tumours.

Authors:  Xiaofeng Tao; Gongxin Yang; Pingzhong Wang; Yingwei Wu; Wenjing Zhu; Huimin Shi; Xin Gong; Weiqing Gao; Qiang Yu
Journal:  Dentomaxillofac Radiol       Date:  2017-04-07       Impact factor: 2.419

2.  Dynamic contrast-enhanced MRI for differentiation of major salivary glands neoplasms, a 3-T MRI study.

Authors:  L Aghaghazvini; F Salahshour; N Yazdani; H Sharifian; S Kooraki; M Pakravan; M Shakiba
Journal:  Dentomaxillofac Radiol       Date:  2014-10-09       Impact factor: 2.419

3.  Misleading initial histological diagnosis of a polymorphous low-grade adenocarcinoma in situ ex pleomorphic adenoma-a case report.

Authors:  P W Kämmerer; A Kreft; T Toyoshima; B Al-Nawas; M O Klein
Journal:  Oral Maxillofac Surg       Date:  2009-06

4.  Management of parotid gland surgery in a university teaching hospital.

Authors:  Sophie Deneuve; Stephanie Quesnel; Joel Depondt; Sebastien Albert; Alexandra Panajotopoulos; Pierre Gehanno; Beatrix Barry
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-09-18       Impact factor: 2.503

5.  Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions.

Authors:  Sarah L Anzick; Wei-Dong Chen; Yoonsoo Park; Paul Meltzer; Diana Bell; Adel K El-Naggar; Frederic J Kaye
Journal:  Genes Chromosomes Cancer       Date:  2010-01       Impact factor: 5.006

6.  Trastuzumab for Her2/neu-positive metastatic salivary gland carcinoma: Case report and review of the literature.

Authors:  Belal Firwana; Bassel Atassi; Rim Hasan; Nour Hasan; Ammar Sukari
Journal:  Avicenna J Med       Date:  2012-07

Review 7.  Use of the SMAS flap for reconstruction of the parotid lodge.

Authors:  G Dell'Aversana Orabona; G Salzano; V Abbate; P Piombino; F Astarita; G Iaconetta; L Califano
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-12       Impact factor: 2.124

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.